arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ORTHOPEDIATRICS CORP

KIDS
$32.20 ▼ -1.32 (-3.94%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
12 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
27
Health
Poor
Bearish
auto_awesome

Analytical Summary

ORTHOPEDIATRICS CORP faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $755.4M
Dividend Yield —
Revenue Growth 15.4% ↘
Op. Margin -16.6% ↗
ROIC -8.8% ↘
FCF / Share $-0.68 ↗
Trailing P/E —
Price / Book 2.3x
FCF Yield —
Debt / Equity 0.31
info Valuation on last close. End-of-day price, Nov 5, 2026.

12-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$236.35M
↑ +15.4% —
Net Income Profit after all expenses
$-39.65M
↓ -4.8% —
Operating Margin Operating profit as % of sales
-16.6%
↑ +2.9% 11th
FCF / Share Free cash flow per share
$-0.68
↑ +62.0% —
Long-Term Debt Long-term obligations
$106.01M
↑ +36.8% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
12
Returns ↓
33
Financial Health →
33
Cash Quality ↓
36

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 12 years · 43 quarters